MAM
KNTE

Martingale Asset Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Martingale Asset Management’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,822
Closed -$136K – 893
2023
Q1 		$136K Sell
21,822
-700
-3% -$4.38K ﹤0.01% 797
2022
Q4 		$137K Buy
+22,522
New +$137K ﹤0.01% 813